This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic
inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner the book
starts with an introduction to cardiometabolic risk and its clinical relevance comparing
emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers
in a range of diseases including diabetes ischemic stroke and neurodegenerative disorders.
Biomarkers of Cardiometabolic Risk Inflammation and Disease is aimed at doctors specializing
in internal medicine neurology cardiology rheumatology nephrology or endocrinology and will
also be of interest to GPs trainee doctors and clinical and basic researchers working on
cardiovascular and autoimmune disorders.
